Pharma & Healthcare
Global Alfuzosin Hydrochloride Sustained Release Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 607043
- Pages: 155
- Figures: 166
- Views: 1
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Alfuzosin Hydrochloride Sustained Release Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Mylan
Teva
Apotex
Torrent Pharmaceuticals
Sun Pharma
Aurobindo
Wockhardt
Unichem Laboratories
Sanofi
Lunanbet Pharmaceutical
CSPC Pharmaceutical Group
Segment by Type
2.5mg
5mg
10mg
Segment by Application
Hospital
Clinic
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Alfuzosin Hydrochloride Sustained Release Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Alfuzosin Hydrochloride Sustained Release Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Mylan
Teva
Apotex
Torrent Pharmaceuticals
Sun Pharma
Aurobindo
Wockhardt
Unichem Laboratories
Sanofi
Lunanbet Pharmaceutical
CSPC Pharmaceutical Group
Segment by Type
2.5mg
5mg
10mg
Segment by Application
Hospital
Clinic
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Alfuzosin Hydrochloride Sustained Release Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Alfuzosin Hydrochloride Sustained Release Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.3 Market Segmentation by Application
1.3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 2.5mg Market Size by Manufacturers
3.5.2 5mg Market Size by Manufacturers
3.5.3 10mg Market Size by Manufacturers
3.6 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
6.4 North America Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
7.4 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Mylan
11.1.1 Mylan Corporation Information
11.1.2 Mylan Business Overview
11.1.3 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.1.4 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.1.6 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.1.7 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.1.8 Mylan Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.1.9 Mylan Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Business Overview
11.2.3 Teva Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.2.4 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.2.6 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.2.7 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.2.8 Teva Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.2.9 Teva Recent Developments
11.3 Apotex
11.3.1 Apotex Corporation Information
11.3.2 Apotex Business Overview
11.3.3 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.3.4 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.3.6 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.3.7 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.3.8 Apotex Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.3.9 Apotex Recent Developments
11.4 Torrent Pharmaceuticals
11.4.1 Torrent Pharmaceuticals Corporation Information
11.4.2 Torrent Pharmaceuticals Business Overview
11.4.3 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.4.4 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.4.6 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.4.7 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.4.8 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.4.9 Torrent Pharmaceuticals Recent Developments
11.5 Sun Pharma
11.5.1 Sun Pharma Corporation Information
11.5.2 Sun Pharma Business Overview
11.5.3 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.5.4 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.5.6 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.5.7 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.5.8 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.5.9 Sun Pharma Recent Developments
11.6 Aurobindo
11.6.1 Aurobindo Corporation Information
11.6.2 Aurobindo Business Overview
11.6.3 Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.6.4 Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Aurobindo Recent Developments
11.7 Wockhardt
11.7.1 Wockhardt Corporation Information
11.7.2 Wockhardt Business Overview
11.7.3 Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.7.4 Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Wockhardt Recent Developments
11.8 Unichem Laboratories
11.8.1 Unichem Laboratories Corporation Information
11.8.2 Unichem Laboratories Business Overview
11.8.3 Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.8.4 Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Unichem Laboratories Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.9.4 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Sanofi Recent Developments
11.10 Lunanbet Pharmaceutical
11.10.1 Lunanbet Pharmaceutical Corporation Information
11.10.2 Lunanbet Pharmaceutical Business Overview
11.10.3 Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.10.4 Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Lunanbet Pharmaceutical Recent Developments
11.11 CSPC Pharmaceutical Group
11.11.1 CSPC Pharmaceutical Group Corporation Information
11.11.2 CSPC Pharmaceutical Group Business Overview
11.11.3 CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.11.4 CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 CSPC Pharmaceutical Group Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Alfuzosin Hydrochloride Sustained Release Tablets Industry Chain
12.2 Alfuzosin Hydrochloride Sustained Release Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Alfuzosin Hydrochloride Sustained Release Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Alfuzosin Hydrochloride Sustained Release Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Alfuzosin Hydrochloride Sustained Release Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Alfuzosin Hydrochloride Sustained Release Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Alfuzosin Hydrochloride Sustained Release Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.3 Market Segmentation by Application
1.3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 2.5mg Market Size by Manufacturers
3.5.2 5mg Market Size by Manufacturers
3.5.3 10mg Market Size by Manufacturers
3.6 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
6.4 North America Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
7.4 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Mylan
11.1.1 Mylan Corporation Information
11.1.2 Mylan Business Overview
11.1.3 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.1.4 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.1.6 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.1.7 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.1.8 Mylan Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.1.9 Mylan Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Business Overview
11.2.3 Teva Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.2.4 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.2.6 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.2.7 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.2.8 Teva Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.2.9 Teva Recent Developments
11.3 Apotex
11.3.1 Apotex Corporation Information
11.3.2 Apotex Business Overview
11.3.3 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.3.4 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.3.6 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.3.7 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.3.8 Apotex Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.3.9 Apotex Recent Developments
11.4 Torrent Pharmaceuticals
11.4.1 Torrent Pharmaceuticals Corporation Information
11.4.2 Torrent Pharmaceuticals Business Overview
11.4.3 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.4.4 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.4.6 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.4.7 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.4.8 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.4.9 Torrent Pharmaceuticals Recent Developments
11.5 Sun Pharma
11.5.1 Sun Pharma Corporation Information
11.5.2 Sun Pharma Business Overview
11.5.3 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.5.4 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales by Product in 2024
11.5.6 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application in 2024
11.5.7 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Area in 2024
11.5.8 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
11.5.9 Sun Pharma Recent Developments
11.6 Aurobindo
11.6.1 Aurobindo Corporation Information
11.6.2 Aurobindo Business Overview
11.6.3 Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.6.4 Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Aurobindo Recent Developments
11.7 Wockhardt
11.7.1 Wockhardt Corporation Information
11.7.2 Wockhardt Business Overview
11.7.3 Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.7.4 Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Wockhardt Recent Developments
11.8 Unichem Laboratories
11.8.1 Unichem Laboratories Corporation Information
11.8.2 Unichem Laboratories Business Overview
11.8.3 Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.8.4 Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Unichem Laboratories Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.9.4 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Sanofi Recent Developments
11.10 Lunanbet Pharmaceutical
11.10.1 Lunanbet Pharmaceutical Corporation Information
11.10.2 Lunanbet Pharmaceutical Business Overview
11.10.3 Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.10.4 Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Lunanbet Pharmaceutical Recent Developments
11.11 CSPC Pharmaceutical Group
11.11.1 CSPC Pharmaceutical Group Corporation Information
11.11.2 CSPC Pharmaceutical Group Business Overview
11.11.3 CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Product Models, Descriptions and Specifications
11.11.4 CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 CSPC Pharmaceutical Group Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Alfuzosin Hydrochloride Sustained Release Tablets Industry Chain
12.2 Alfuzosin Hydrochloride Sustained Release Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Alfuzosin Hydrochloride Sustained Release Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Alfuzosin Hydrochloride Sustained Release Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Alfuzosin Hydrochloride Sustained Release Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Alfuzosin Hydrochloride Sustained Release Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Alfuzosin Hydrochloride Sustained Release Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alfuzosin Hydrochloride Sustained Release Tablets as of 2024)
Table 16. Global Alfuzosin Hydrochloride Sustained Release Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Alfuzosin Hydrochloride Sustained Release Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base and Headquarters
Table 19. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Alfuzosin Hydrochloride Sustained Release Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Alfuzosin Hydrochloride Sustained Release Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Alfuzosin Hydrochloride Sustained Release Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Alfuzosin Hydrochloride Sustained Release Tablets Growth Accelerators and Market Barriers
Table 37. North America Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Alfuzosin Hydrochloride Sustained Release Tablets Growth Accelerators and Market Barriers
Table 40. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Mylan Corporation Information
Table 51. Mylan Description and Major Businesses
Table 52. Mylan Product Models, Descriptions and Specifications
Table 53. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Mylan Sales Value Proportion by Product in 2024
Table 55. Mylan Sales Value Proportion by Application in 2024
Table 56. Mylan Sales Value Proportion by Geographic Area in 2024
Table 57. Mylan Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 58. Mylan Recent Developments
Table 59. Teva Corporation Information
Table 60. Teva Description and Major Businesses
Table 61. Teva Product Models, Descriptions and Specifications
Table 62. Teva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Teva Sales Value Proportion by Product in 2024
Table 64. Teva Sales Value Proportion by Application in 2024
Table 65. Teva Sales Value Proportion by Geographic Area in 2024
Table 66. Teva Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 67. Teva Recent Developments
Table 68. Apotex Corporation Information
Table 69. Apotex Description and Major Businesses
Table 70. Apotex Product Models, Descriptions and Specifications
Table 71. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Apotex Sales Value Proportion by Product in 2024
Table 73. Apotex Sales Value Proportion by Application in 2024
Table 74. Apotex Sales Value Proportion by Geographic Area in 2024
Table 75. Apotex Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 76. Apotex Recent Developments
Table 77. Torrent Pharmaceuticals Corporation Information
Table 78. Torrent Pharmaceuticals Description and Major Businesses
Table 79. Torrent Pharmaceuticals Product Models, Descriptions and Specifications
Table 80. Torrent Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Torrent Pharmaceuticals Sales Value Proportion by Product in 2024
Table 82. Torrent Pharmaceuticals Sales Value Proportion by Application in 2024
Table 83. Torrent Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 84. Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 85. Torrent Pharmaceuticals Recent Developments
Table 86. Sun Pharma Corporation Information
Table 87. Sun Pharma Description and Major Businesses
Table 88. Sun Pharma Product Models, Descriptions and Specifications
Table 89. Sun Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sun Pharma Sales Value Proportion by Product in 2024
Table 91. Sun Pharma Sales Value Proportion by Application in 2024
Table 92. Sun Pharma Sales Value Proportion by Geographic Area in 2024
Table 93. Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 94. Sun Pharma Recent Developments
Table 95. Aurobindo Corporation Information
Table 96. Aurobindo Description and Major Businesses
Table 97. Aurobindo Product Models, Descriptions and Specifications
Table 98. Aurobindo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Aurobindo Recent Developments
Table 100. Wockhardt Corporation Information
Table 101. Wockhardt Description and Major Businesses
Table 102. Wockhardt Product Models, Descriptions and Specifications
Table 103. Wockhardt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Wockhardt Recent Developments
Table 105. Unichem Laboratories Corporation Information
Table 106. Unichem Laboratories Description and Major Businesses
Table 107. Unichem Laboratories Product Models, Descriptions and Specifications
Table 108. Unichem Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Unichem Laboratories Recent Developments
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Major Businesses
Table 112. Sanofi Product Models, Descriptions and Specifications
Table 113. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Sanofi Recent Developments
Table 115. Lunanbet Pharmaceutical Corporation Information
Table 116. Lunanbet Pharmaceutical Description and Major Businesses
Table 117. Lunanbet Pharmaceutical Product Models, Descriptions and Specifications
Table 118. Lunanbet Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Lunanbet Pharmaceutical Recent Developments
Table 120. CSPC Pharmaceutical Group Corporation Information
Table 121. CSPC Pharmaceutical Group Description and Major Businesses
Table 122. CSPC Pharmaceutical Group Product Models, Descriptions and Specifications
Table 123. CSPC Pharmaceutical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. CSPC Pharmaceutical Group Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Alfuzosin Hydrochloride Sustained Release Tablets Product Picture
Figure 2. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 2.5mg Product Picture
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Alfuzosin Hydrochloride Sustained Release Tablets Report Years Considered
Figure 11. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 13. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Region (2020-2031)
Figure 15. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (2020-2031) & (K Units)
Figure 16. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume Market Share in 2024
Figure 19. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. 2.5mg Revenue Market Share by Manufacturer in 2024
Figure 22. 5mg Revenue Market Share by Manufacturer in 2024
Figure 23. 10mg Revenue Market Share by Manufacturer in 2024
Figure 24. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2020-2031)
Figure 25. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Type (2020-2031)
Figure 26. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2020-2031)
Figure 27. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Application (2020-2031)
Figure 28. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 29. North America Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 31. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 41. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 46. France Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 61. India Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 82. Alfuzosin Hydrochloride Sustained Release Tablets Industry Chain Mapping
Figure 83. Regional Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base Distribution (%)
Figure 84. Global Alfuzosin Hydrochloride Sustained Release Tablets Production Market Share by Region (2020-2031)
Figure 85. Alfuzosin Hydrochloride Sustained Release Tablets Production Process
Figure 86. Regional Alfuzosin Hydrochloride Sustained Release Tablets Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Table 1. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Alfuzosin Hydrochloride Sustained Release Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alfuzosin Hydrochloride Sustained Release Tablets as of 2024)
Table 16. Global Alfuzosin Hydrochloride Sustained Release Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Alfuzosin Hydrochloride Sustained Release Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base and Headquarters
Table 19. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Alfuzosin Hydrochloride Sustained Release Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Alfuzosin Hydrochloride Sustained Release Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Alfuzosin Hydrochloride Sustained Release Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Alfuzosin Hydrochloride Sustained Release Tablets Growth Accelerators and Market Barriers
Table 37. North America Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Alfuzosin Hydrochloride Sustained Release Tablets Growth Accelerators and Market Barriers
Table 40. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Mylan Corporation Information
Table 51. Mylan Description and Major Businesses
Table 52. Mylan Product Models, Descriptions and Specifications
Table 53. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Mylan Sales Value Proportion by Product in 2024
Table 55. Mylan Sales Value Proportion by Application in 2024
Table 56. Mylan Sales Value Proportion by Geographic Area in 2024
Table 57. Mylan Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 58. Mylan Recent Developments
Table 59. Teva Corporation Information
Table 60. Teva Description and Major Businesses
Table 61. Teva Product Models, Descriptions and Specifications
Table 62. Teva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Teva Sales Value Proportion by Product in 2024
Table 64. Teva Sales Value Proportion by Application in 2024
Table 65. Teva Sales Value Proportion by Geographic Area in 2024
Table 66. Teva Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 67. Teva Recent Developments
Table 68. Apotex Corporation Information
Table 69. Apotex Description and Major Businesses
Table 70. Apotex Product Models, Descriptions and Specifications
Table 71. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Apotex Sales Value Proportion by Product in 2024
Table 73. Apotex Sales Value Proportion by Application in 2024
Table 74. Apotex Sales Value Proportion by Geographic Area in 2024
Table 75. Apotex Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 76. Apotex Recent Developments
Table 77. Torrent Pharmaceuticals Corporation Information
Table 78. Torrent Pharmaceuticals Description and Major Businesses
Table 79. Torrent Pharmaceuticals Product Models, Descriptions and Specifications
Table 80. Torrent Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Torrent Pharmaceuticals Sales Value Proportion by Product in 2024
Table 82. Torrent Pharmaceuticals Sales Value Proportion by Application in 2024
Table 83. Torrent Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 84. Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 85. Torrent Pharmaceuticals Recent Developments
Table 86. Sun Pharma Corporation Information
Table 87. Sun Pharma Description and Major Businesses
Table 88. Sun Pharma Product Models, Descriptions and Specifications
Table 89. Sun Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sun Pharma Sales Value Proportion by Product in 2024
Table 91. Sun Pharma Sales Value Proportion by Application in 2024
Table 92. Sun Pharma Sales Value Proportion by Geographic Area in 2024
Table 93. Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets SWOT Analysis
Table 94. Sun Pharma Recent Developments
Table 95. Aurobindo Corporation Information
Table 96. Aurobindo Description and Major Businesses
Table 97. Aurobindo Product Models, Descriptions and Specifications
Table 98. Aurobindo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Aurobindo Recent Developments
Table 100. Wockhardt Corporation Information
Table 101. Wockhardt Description and Major Businesses
Table 102. Wockhardt Product Models, Descriptions and Specifications
Table 103. Wockhardt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Wockhardt Recent Developments
Table 105. Unichem Laboratories Corporation Information
Table 106. Unichem Laboratories Description and Major Businesses
Table 107. Unichem Laboratories Product Models, Descriptions and Specifications
Table 108. Unichem Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Unichem Laboratories Recent Developments
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Major Businesses
Table 112. Sanofi Product Models, Descriptions and Specifications
Table 113. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Sanofi Recent Developments
Table 115. Lunanbet Pharmaceutical Corporation Information
Table 116. Lunanbet Pharmaceutical Description and Major Businesses
Table 117. Lunanbet Pharmaceutical Product Models, Descriptions and Specifications
Table 118. Lunanbet Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Lunanbet Pharmaceutical Recent Developments
Table 120. CSPC Pharmaceutical Group Corporation Information
Table 121. CSPC Pharmaceutical Group Description and Major Businesses
Table 122. CSPC Pharmaceutical Group Product Models, Descriptions and Specifications
Table 123. CSPC Pharmaceutical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. CSPC Pharmaceutical Group Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Alfuzosin Hydrochloride Sustained Release Tablets Product Picture
Figure 2. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 2.5mg Product Picture
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Alfuzosin Hydrochloride Sustained Release Tablets Report Years Considered
Figure 11. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 13. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Region (2020-2031)
Figure 15. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (2020-2031) & (K Units)
Figure 16. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume Market Share in 2024
Figure 19. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. 2.5mg Revenue Market Share by Manufacturer in 2024
Figure 22. 5mg Revenue Market Share by Manufacturer in 2024
Figure 23. 10mg Revenue Market Share by Manufacturer in 2024
Figure 24. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2020-2031)
Figure 25. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Type (2020-2031)
Figure 26. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2020-2031)
Figure 27. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Application (2020-2031)
Figure 28. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 29. North America Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 31. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 41. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 46. France Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 61. India Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue (2020-2025) & (US$ Million)
Figure 82. Alfuzosin Hydrochloride Sustained Release Tablets Industry Chain Mapping
Figure 83. Regional Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base Distribution (%)
Figure 84. Global Alfuzosin Hydrochloride Sustained Release Tablets Production Market Share by Region (2020-2031)
Figure 85. Alfuzosin Hydrochloride Sustained Release Tablets Production Process
Figure 86. Regional Alfuzosin Hydrochloride Sustained Release Tablets Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232